Type 2 diabetes and CKD: safety of metformin vs sulfonylureas

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1787卷 / 1期
关键词：
D O I：
10.1007/s40278-020-73650-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：12 / 12
相关论文
共 50 条
  • [21] Effects of pioglitazone versus metformin on endothelial function in patients with type 2 diabetes treated with sulfonylureas
    Naka, K. K.
    Papathanassiou, K.
    Bechlioulis, A.
    Pappas, K.
    Kazakos, N.
    Kanioglou, C.
    Vezyraki, P.
    Makriyiannis, D.
    Tsatsoulis, A.
    Michalis, L. K.
    EUROPEAN HEART JOURNAL, 2011, 32 : 65 - 66
  • [22] Failure of sulfonylureas in type 2 diabetes
    Yildiz, BO
    Gürlek, A
    HORMONE AND METABOLIC RESEARCH, 1999, 31 (04) : 293 - 293
  • [23] Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany
    Goke, R.
    Gruenberger, J. B.
    Bader, G.
    Dworak, M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (05) : 785 - 789
  • [24] Increased Cancer Risk with Sulfonylureas vs Metformin in Women with Diabetes: An Observational Cohort Study
    Sun, Grace
    Wells, Brian
    Zimmerman, Robert
    Kattan, Michael W.
    Kashyap, Sangeeta R.
    DIABETES, 2011, 60 : A371 - A371
  • [25] Cardiovascular safety of metformin and sulphonylureas in type 2 diabetes patients
    Ioacara, S.
    Roden, M.
    Guja, C.
    Ionescu-Tirgoviste, C.
    Reghina, A.
    Georgescu, O.
    Fica, S.
    DIABETOLOGIA, 2014, 57 : S318 - S318
  • [26] The safety of empagliflozin plus metformin for the treatment of type 2 diabetes
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (08) : 837 - 848
  • [27] SGLT2-Inhibitors vs. Sulfonylureas in the Therapy of Type-2-Diabetes
    Gappa, Birgit
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (22) : 1443 - 1444
  • [28] Efficacy and safety of combination therapy with vildagliptin and metformin vs, metformin monotherapy for Type 2 Diabetes Mellitus therapy: a meta-analysis
    Ding, Y.
    Liu, Y.
    Qu, Y.
    Lin, M.
    Dong, F.
    Li, Y.
    Cao, L.
    Lin, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (08) : 2802 - 2817
  • [29] Review: Metformin is linked to reduced mortality in type 2 diabetes with comorbid CKD and CHF
    Jasim, Sina
    Smith, Steven A.
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (08) : JC46 - JC46
  • [30] Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?
    Stanton, Robert C.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (02) : 193 - 195
12345